18.03.2022 • News

Azelis Buys Whitfield Chemical

Azelis has bought Whitfield Chemical, the owner of WhitChem, a UK distributor focused on the coatings, adhesives, sealants and elastomers (CASE) and rubber and plastic additives (R&PA) market segments. Financial terms of the deal, Azelis’s third so far this year, were not disclosed.

Based in Newcastle-under-Lyme, WhitChem has 30 employees and generates most of its sales in the UK, while also making some exports to Ireland.

Commenting on WhitChem, Anna Bertona, CEO & president, Azelis EMEA, said: “Their exemplary expertise, strong relationships and a diverse customer base complement the organic growth of Azelis, while at the same time providing a valuable addition for our lateral value chain for this growing market.”

WhitChem’s managing director Charles Hawley added: “We see many cross-selling opportunities with our complementary product portfolios. CASE and R&PA are exciting markets that have seen significant growth of late and we are eager to expand our product offering and innovative services to the combined customer base.”

In the first two months of this year, Azelis purchased Turkish food ingredients and additives distributor Tunckaya, as well as a majority stake in Thailand’s Catalite, a distributor of specialty chemicals to the personal care and home care market segments, as well as industrial formulations, intermediates and coatings.

Author: Elaine Burridge, Freelance Journalist

(c) Azelis
(c) Azelis

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read